Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rapid MicroGel
- Development stage
- Unknown
- Lead developer
- Tetra Corporation
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Rapid MicroGel is a topical antifungal microemulsion gel developed by Tetra Corporation, containing 1% tolnaftate as its active pharmaceutical ingredient. Specifically formulated to treat macerated tissue and fungal skin conditions such as athlete's foot (tinea pedis) and ringworm (tinea corporis), the product targets dermatophyte fungi by inhibiting the enzyme squalene epoxidase, thereby disrupting ergosterol biosynthesis. The gel is unique for its ability to liquefy at body temperature and its use of penetration enhancers, including N-acetyl-l-cysteine, to facilitate the delivery of tolnaftate to the site of infection. It also incorporates cosmetic conditioners and astringents to dry the skin and restore barrier function. Rapid MicroGel is an FDA-approved over-the-counter (OTC) medication and represents a reformulated relaunch of the company's Formula 7 Solution.
- Brand names
- Rapid MicroGel
- Other names
- Formula 7 SolutionFormula7 SolutionFormula-7 Solution
02
Targets
SQLE (Squalene monooxygenase)
Beyond the preview
Go deeper on Rapid MicroGel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rapid MicroGel.